Pharmaceutical

LimmaTech secures funding for vaccine technology development

LimmaTech announced the closing of a second round of its Series A financing, securing $3m from Tenmile for vaccine technology development.

Feb 2, 2024 - 18:00
LimmaTech secures funding for vaccine technology development
LimmaTech announced the closing of a second round of its Series A financing, securing $3m from Tenmile for vaccine technology development.
Read the original article

Tags:

Previous Article

Scottish company secures £4.2m to advance 3D-printed micro-tumour tech

Next Article

Biosyngen’s liver cancer therapy receives fast track designation

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: To lower drug prices, White House takes new aim at pharma patents

STAT+: To lower drug prices, White House takes new aim ...

Dec 7, 2023

Panbela obtains rights to develop and commercialise Flynpovi to treat FAP

Panbela obtains rights to develop and commercialise Fly...

Apr 12, 2023

UK Government to launch first ever men’s health strategy

UK Government to launch first ever men’s health strategy

Dec 1, 2024